RELATIONSHIP BETWEEN ONE-STAGE AND CHROMOGENIC FVIII ASSAY DISCREPANCIES AND GENETIC ANALYSIS OF FVIII GENE IN PATIENTS WITH NON-SEVERE HAEMOPHILIA A

被引:0
|
作者
Obregon, J. [1 ]
Calvo Villas, J. M. [1 ]
Marco Rico, A. [2 ]
Herrero Martin, S. [3 ]
Urena, L. E. [4 ]
Lopez Jaime, F. J. [5 ]
Diaz Jordan, B. [6 ]
Garcia Diaz, C. [7 ]
Jurado Herrera, S. [8 ]
Perez Gonzalez, N. F. [8 ]
Garcia Candel, F. [9 ]
Marco Vera, P.
Fernandez Bello, I.
Montano Brioso, A. [10 ]
机构
[1] Hosp Univ Miguel Servet, Zaragoza, Spain
[2] Hosp Gen Univ Alicante Doctor Balmis, Alicante, Spain
[3] Hosp Univ Guadalajara, Guadalajara, Spain
[4] Hosp Univ Virgen Ias Nieves, Granada, Spain
[5] Hosp Univ Reg Malaga, Malaga, Spain
[6] Hosp Gen Valdepenas, Ciudad Real, Spain
[7] Hosp Univ Burgos, Burgos, Spain
[8] Hosp Univ Torrcardenas, Almeria, Spain
[9] Hosp Clin Univ Virgen Arrixaca, Murcia, Spain
[10] Univ Salamanca, Hosp Univ Reg Malaga, Malaga, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PO007
引用
收藏
页码:26 / 27
页数:2
相关论文
共 37 条
  • [1] ONE STAGE CHRONOMETRIC FVIII ASSAY OR TWO STAGE CHROMOGENIC FVIII ASSAY TO DIAGNOSE HAEMOPHILIA A?
    Marchand, K.
    Benoit, R.
    Martin, M.
    Fretigny, M.
    Toussaint-Hacquard, M.
    Frotscher, B.
    HAEMOPHILIA, 2022, 28 : 30 - 30
  • [2] One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype
    Cid, A. R.
    Calabuig, M.
    Cortina, V.
    Casana, P.
    Haya, S.
    Moret, A.
    Cabrera, N.
    Aznar, J. A.
    HAEMOPHILIA, 2008, 14 (05) : 1049 - 1054
  • [3] Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B
    Kihlberg, Kristina
    Strandberg, Karin
    Ljung, Rolf
    Berntorp, Erik
    Astermark, Jan
    HAEMOPHILIA, 2016, 22 : 70 - 70
  • [4] Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B
    Kihlberg, K.
    Strandberg, K.
    Rosen, S.
    Ljung, R.
    Astermark, J.
    HAEMOPHILIA, 2017, 23 (04) : 620 - 627
  • [5] Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assay
    Provaznikova, D.
    Houskova, K.
    Radovska, A.
    Hrachovinova, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 833 - 833
  • [6] Discrepant one-stage clotting versus chromogenic FVIII assays in haemophilia patients on Refacto AF
    Anwar, M.
    Uprichard, J.
    Austin, S. K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 13 - 13
  • [7] Prevalence of discrepancy between one-stage and chromogenic FVIII activity assays and the mutation profile in Polish mild/moderate haemophilia A patients
    Baran, Beata
    Odnoczko, Edyta
    Stefanska-Windyga, Ewa
    Pavlova, Anna
    Oldenburg, Johannes
    Windyga, Jerzy
    HAEMOPHILIA, 2016, 22 : 75 - 75
  • [8] Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays
    Pavlova, Anna
    Delev, Daniel
    Pezeshkpoor, Behnaz
    Mueller, Jens
    Oldenburg, Johannes
    THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 851 - 861
  • [9] FVIII OS/CS ratios for select novel recombinant fviii replacement products measured in four FDA approved FVIII one-stage clot assay systems and one chromogenic assay
    Tiefenbacher, S.
    Robinson, M. M.
    Ross, E. L.
    Williams, P. T.
    Cogswell, C. E.
    Wham, T. L.
    Chow, G. K.
    Adcock, D. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 836 - 836
  • [10] Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assays
    Provaznikova, D.
    Houskova, K.
    Radovska, A.
    Salaj, P.
    Hrachovinova, I.
    HAEMOPHILIA, 2015, 21 (04) : E330 - E332